Evidence map›Paper›PMID 34770830›Full record

ArticleMolecules (Basel, Switzerland)2021

Neuroprotective Effects of B-Type Cinnamon Procyanidin Oligomers on MPP

Qi Xu, Ziyu Chen, Borong Zhu, Yiming Li, Manju B Reddy, Huilin Liu, Guodong Dang, Qi Jia, Xiaojun Wu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Qi XuSchool of Public Health, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.
Ziyu ChenShanghai Key Laboratory of Compound Chinese Medicine, The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.
Borong ZhuSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.
Yiming LiSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.ORCID 0000-0003-3416-1331
Manju B ReddyDepartment of Food Science and Human Nutrition, Iowa State University, Ames, IA 50010, USA.ORCID 0000-0002-2294-0701
Huilin LiuSchool of Public Health, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.
Guodong DangSchool of Public Health, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.
Qi JiaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.
Xiaojun WuShanghai Key Laboratory of Compound Chinese Medicine, The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicine, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.
Shanghai University of Traditional Chinese Medicine · CNIowa State University · US

Funding

Funding of Shanghai Health Commission 2020JP006Funding of Shanghai University of Traditional Chinese Medicine GJ202101National Natural Science Foundation of China 81773791
6 · The paper itself

Abstract

Cinnamon procyanidin oligomers (CPOs) are water-soluble components extracted from cinnamon. This study aims to explore the neuroprotection of B-type CPO (CPO-B) against 1-methyl-4-phenylpyridinium (MPP

Indexed as

1-Methyl-4-phenylpyridiniumApoptosisBiflavonoidsCatechinCell ProliferationCell SurvivalCinnamomum zeylanicumHumansNeuroprotective AgentsParkinson DiseaseProanthocyanidinsTumor Cells, Cultured1-Methyl-4-phenylpyridiniumBiflavonoidsCatechinNeuroprotective AgentsProanthocyanidinsprocyanidinCPO-BErk1/2MPP+neuroprotectionParkinson’s disease

Identifiers

PMID34770830
PMCPMC8587825
OpenAlexW3208168061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.